Azilsartan medoxomil is in a group of drugs called angiotensin II receptor antagonists. Azilsartan medoxomil keeps blood vessels from narrowing, which lowers blood pressure and improves blood flow.
This report contains market size and forecasts of Azilsartan Medoxomil API in global, including the following market information:
Global Azilsartan Medoxomil API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Azilsartan Medoxomil API Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Azilsartan Medoxomil API companies in 2021 (%)
The global Azilsartan Medoxomil API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Azilsartan Medoxomil API include Tecoland, FCDA, A ChemTek, Clearsynth, Ami Lifesciences, Metrochem API, SGMR Pharmaceuticals, Beijing Xinyitai and Hubei Lansun Biochemistry Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Azilsartan Medoxomil API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Azilsartan Medoxomil API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Azilsartan Medoxomil API Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Azilsartan Medoxomil API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Azilsartan Medoxomil API Market Segment Percentages, by Application, 2021 (%)
Research
Pharmaceutical
Global Azilsartan Medoxomil API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Azilsartan Medoxomil API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Azilsartan Medoxomil API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Azilsartan Medoxomil API revenues share in global market, 2021 (%)
Key companies Azilsartan Medoxomil API sales in global market, 2017-2022 (Estimated), (MT)
Key companies Azilsartan Medoxomil API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Tecoland
FCDA
A ChemTek
Clearsynth
Ami Lifesciences
Metrochem API
SGMR Pharmaceuticals
Beijing Xinyitai
Hubei Lansun Biochemistry Pharmaceutical
Rundu Pharma
Tianyu Pharm
Jiangxi Synergy Pharmaceutical